Vinge advises Embracer in connection with a SEK 6 bn RCF

Vinge advises Embracer Group AB (publ) in connection with the signing of a new SEK 6,000,000,000 revolving credit facility.

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of VEAB Ventilation Entreprenad

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ventilation Entreprenad VEAB, Veab Ventilation Entreprenad i Kristianstad, VEAB Ventilation Entreprenad I Helsingborg, Styr Entreprenad i Malmö and Energi & Klimatteknik i Tygelsjö.

Vinge advises ZetaDisplay on the public offer from Hanover

Hanover Active Equity Fund II has announced a public offer to the shareholders of ZetaDisplay AB (publ). The total value of the offer is SEK 710 million.

Vinge advises consortium led by Advent International on acquisition of Hoist Group Holding Intressenter AB (publ)

Vinge together with Weil, Gotshal & Manges LLP is advising a consortium led by Advent International in connection with its acquisition of Hoist Group Holding Intressenter AB (publ) (the ”Hoist Group”).

Vinge has advised Main Capital and Alfa eCare in connection with their strategic acquisition of Clinicbuddy

The Alfa eCare group is a recognized eHealth software company, providing solutions to both public and private healthcare providers throughout Sweden.

Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno

Vinge advises Destiny (a portfolio company of Apax Partners) in connection with its acquisition of the Soluno group (“Soluno”).

Vinge is advising Vimian Group AB (publ) (“Vimian”) and the principal shareholder Fidelio Capital AB (“Fidelio”) in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021

Vinge is advising Vimian and the principal shareholder Fidelio in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021, and also with the reorganization preceding the listing. The price in the private placement values Vimian to c. SEK 29.6 billion.

Vinge advises ABG Sundal Collier, Carnegie and Nordea in connection with the listing of RevolutionRace on Nasdaq Stockholm

Vinge advises ABG Sundal Collier, Carnegie and Nordea in connection with the listing of RVRC Holding AB (publ) on Nasdaq Stockholm.

Vinge has advised Priveq Investment in connection with the investment in ROL

Today ROL offers workspace solutions including software and ergonomically optimized office furniture and store concept solutions. ROL’s offering is sold globally both through ROL’s own sales organization and distributors. In 2020, ROL had a turnover of approximately SEK 1.6 billion and 890 employees in ten different countries.

Vinge advises HELLA GmbH in connection with an investment in Gapwaves AB (publ)

HELLA GmbH & Co. KGaA, one of the largest manufacturers of radar in the automotive industry, has made an investment of MSEK 182.3 and entered into a licensing and development agreement with time limited exclusivity for corner and side radar with Gapwaves AB (publ).

Vinge has advised Litorina in connection with the acquisition of Brödernas

Brödernas is a fast-growing restaurant chain focused on serving high-quality burger and pizza in Sweden.

Vinge advises Katam Technologies in connection with a financing round.

Vinge advises Katam Technologies AB in connection with a financing round from Almi Invest Greentech together with private investors. Katam is a global supplier of software services for collection and analysis of forest data.

Vinge advises Isofol in connection with capital procurement

Vinge has advised Isofol Medical AB (publ), Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue and exercised over-allotment option which together add SEK 500 million to Isofol before transaction costs.

Vinge advises Elos Medtech in connection with the public offer from TA Associates

TA Associates has announced a public offer to the shareholders of Elos Medtech AB (publ). The total value of the offer is SEK 1,735 million.

Vinge has advised Sdiptech AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Sdiptech AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market. The prospectus was published on 8 June 2021 and the trading on Nasdaq Stockholm commenced on 11 June 2021.